St. Johns Investment Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-14
| Closed | – | – | 170 |
|
|
2019
Q4 | $0 | Hold |
14
| – | – | ﹤0.01% | 170 |
|
|
2019
Q3 | $0 | Hold |
14
| – | – | ﹤0.01% | 176 |
|
|
2019
Q2 | $0 | Hold |
14
| – | – | ﹤0.01% | 177 |
|
|
2019
Q1 | $0 | Hold |
14
| – | – | ﹤0.01% | 185 |
|
|
2018
Q4 | $0 | Hold |
14
| – | – | ﹤0.01% | 187 |
|
|
2018
Q3 | $0 | Hold |
14
| – | – | ﹤0.01% | 202 |
|
|
2018
Q2 | $0 | Hold |
14
| – | – | ﹤0.01% | 211 |
|
|
2018
Q1 | $0 | Hold |
14
| – | – | ﹤0.01% | 203 |
|
|
2017
Q4 | $0 | Hold |
14
| – | – | ﹤0.01% | 201 |
|
|
2017
Q3 | $0 | Hold |
14
| – | – | ﹤0.01% | 199 |
|
|
2017
Q2 | $0 | Hold |
14
| – | – | ﹤0.01% | 193 |
|
|
2017
Q1 | $0 | Hold |
14
| – | – | ﹤0.01% | 195 |
|
|
2016
Q4 | $0 | Hold |
14
| – | – | ﹤0.01% | 195 |
|
|
2016
Q3 | $0 | Hold |
14
| – | – | ﹤0.01% | 183 |
|
|
2016
Q2 | $0 | Hold |
14
| – | – | ﹤0.01% | 183 |
|
|
2016
Q1 | $0 | Hold |
14
| – | – | ﹤0.01% | 190 |
|
|
2015
Q4 | $0 | Hold |
14
| – | – | ﹤0.01% | 173 |
|
|
2015
Q3 | $0 | Hold |
14
| – | – | ﹤0.01% | 162 |
|
|
2015
Q2 | $0 | Buy |
+14
| New | +$10 | ﹤0.01% | 161 |
|
St. Johns Investment Management's GCVRZ Position: Q1 2020 in Review
St. Johns Investment Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 14 shares.
St. Johns Investment Management first reported a position in GCVRZ in Q2 2015 and held it in 19 quarters. The position peaked at $0 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- St. Johns Investment Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- St. Johns Investment Management sold 14 Sanofi Contingent Value Rights shares in Q1 2020.
- St. Johns Investment Management first reported a position in Sanofi Contingent Value Rights in Q2 2015 and held it in 19 quarters.
- St. Johns Investment Management's Sanofi Contingent Value Rights position peaked at $0 in Q4 2019.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on St. Johns Investment Management's 13F filing for Q1 2020, filed 27 Apr 2020.